nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—Angioedema—Captopril—systemic scleroderma	0.00523	0.00523	CcSEcCtD
Nebivolol—Syncope—Captopril—systemic scleroderma	0.00513	0.00513	CcSEcCtD
Nebivolol—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.00511	0.00511	CcSEcCtD
Nebivolol—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00509	0.00509	CcSEcCtD
Nebivolol—Myocardial infarction—Lisinopril—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Nebivolol—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00504	0.00504	CcSEcCtD
Nebivolol—Loss of consciousness—Captopril—systemic scleroderma	0.00503	0.00503	CcSEcCtD
Nebivolol—Cardiac disorder—Leflunomide—systemic scleroderma	0.00503	0.00503	CcSEcCtD
Nebivolol—Urticaria—Pentoxifylline—systemic scleroderma	0.00489	0.00489	CcSEcCtD
Nebivolol—Chest pain—Captopril—systemic scleroderma	0.00487	0.00487	CcSEcCtD
Nebivolol—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00487	0.00487	CcSEcCtD
Nebivolol—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00479	0.00479	CcSEcCtD
Nebivolol—Paraesthesia—Mometasone—systemic scleroderma	0.00477	0.00477	CcSEcCtD
Nebivolol—Mental disorder—Leflunomide—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Nebivolol—Dyspnoea—Mometasone—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Nebivolol—Bradycardia—Lisinopril—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Nebivolol—Malnutrition—Leflunomide—systemic scleroderma	0.00471	0.00471	CcSEcCtD
Nebivolol—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00469	0.00469	CcSEcCtD
Nebivolol—Shock—Captopril—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Nebivolol—Oedema peripheral—Lisinopril—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Nebivolol—Fatigue—Mometasone—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Nebivolol—Thrombocytopenia—Captopril—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Nebivolol—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Nebivolol—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00453	0.00453	CcSEcCtD
Nebivolol—Malnutrition—Mycophenolic acid—systemic scleroderma	0.0045	0.0045	CcSEcCtD
Nebivolol—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Nebivolol—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Nebivolol—Asthenia—Pentoxifylline—systemic scleroderma	0.00442	0.00442	CcSEcCtD
Nebivolol—Pruritus—Pentoxifylline—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Nebivolol—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Nebivolol—Angioedema—Leflunomide—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Nebivolol—Vertigo—Leflunomide—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Nebivolol—Insomnia—Captopril—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Nebivolol—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Nebivolol—Abdominal pain—Mometasone—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Nebivolol—Paraesthesia—Captopril—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Nebivolol—Dyspnoea—Captopril—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Nebivolol—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Nebivolol—Somnolence—Captopril—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Nebivolol—Mental disorder—Lisinopril—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Nebivolol—Dizziness—Pentoxifylline—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Nebivolol—Malnutrition—Lisinopril—systemic scleroderma	0.00405	0.00405	CcSEcCtD
Nebivolol—Vertigo—Mycophenolic acid—systemic scleroderma	0.00404	0.00404	CcSEcCtD
Nebivolol—Syncope—Mycophenolic acid—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Nebivolol—Fatigue—Captopril—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Nebivolol—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Nebivolol—Chest pain—Leflunomide—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Nebivolol—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Nebivolol—Skin disorder—Azathioprine—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Nebivolol—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Nebivolol—Vomiting—Pentoxifylline—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Nebivolol—Rash—Pentoxifylline—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Nebivolol—Dermatitis—Pentoxifylline—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Nebivolol—Headache—Pentoxifylline—systemic scleroderma	0.00386	0.00386	CcSEcCtD
Nebivolol—Chest pain—Mycophenolic acid—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Nebivolol—Gastrointestinal pain—Captopril—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Nebivolol—Asthenia—Mometasone—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Nebivolol—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Nebivolol—Nervous system disorder—Leflunomide—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Nebivolol—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Nebivolol—Pruritus—Mometasone—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Nebivolol—Skin disorder—Leflunomide—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Nebivolol—Angioedema—Lisinopril—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Nebivolol—Abdominal pain—Captopril—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Nebivolol—Nausea—Pentoxifylline—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Nebivolol—Vertigo—Lisinopril—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Nebivolol—Diarrhoea—Mometasone—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Nebivolol—Syncope—Lisinopril—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Nebivolol—Renal failure acute—Methotrexate—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Nebivolol—Shock—Mycophenolic acid—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Nebivolol—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Nebivolol—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Nebivolol—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Nebivolol—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Nebivolol—Loss of consciousness—Lisinopril—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Nebivolol—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Nebivolol—Insomnia—Leflunomide—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Nebivolol—Paraesthesia—Leflunomide—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Nebivolol—Chest pain—Lisinopril—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Nebivolol—Dyspnoea—Leflunomide—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Nebivolol—Vomiting—Mometasone—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Nebivolol—Rash—Mometasone—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Nebivolol—Asthenia—Captopril—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Nebivolol—Dermatitis—Mometasone—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Nebivolol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Nebivolol—Headache—Mometasone—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Nebivolol—Insomnia—Mycophenolic acid—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Nebivolol—Fatigue—Leflunomide—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Nebivolol—Pruritus—Captopril—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Nebivolol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Nebivolol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Nebivolol—Somnolence—Mycophenolic acid—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Nebivolol—Shock—Lisinopril—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Nebivolol—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Nebivolol—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Nebivolol—Abdominal pain—Azathioprine—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Nebivolol—Skin disorder—Lisinopril—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Nebivolol—Diarrhoea—Captopril—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Nebivolol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Nebivolol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Nebivolol—Erectile dysfunction—Prednisone—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Nebivolol—Fatigue—Mycophenolic acid—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Nebivolol—Nausea—Mometasone—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Nebivolol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Nebivolol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Nebivolol—Dizziness—Captopril—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Nebivolol—Urticaria—Leflunomide—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Nebivolol—Abdominal pain—Leflunomide—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Nebivolol—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Nebivolol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Nebivolol—Myocardial infarction—Prednisone—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Nebivolol—Hypersensitivity—Azathioprine—systemic scleroderma	0.003	0.003	CcSEcCtD
Nebivolol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.003	0.003	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.003	0.003	CcSEcCtD
Nebivolol—Insomnia—Lisinopril—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Nebivolol—Paraesthesia—Lisinopril—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Nebivolol—Vomiting—Captopril—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Nebivolol—Dyspnoea—Lisinopril—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Nebivolol—Rash—Captopril—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Nebivolol—Dermatitis—Captopril—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Nebivolol—Somnolence—Lisinopril—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Nebivolol—Headache—Captopril—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Nebivolol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Nebivolol—Fatigue—Lisinopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Nebivolol—Shock—Mycophenolate mofetil—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Nebivolol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Nebivolol—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Nebivolol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Nebivolol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Nebivolol—Bradycardia—Prednisone—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Nebivolol—Diarrhoea—Azathioprine—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Nebivolol—Nausea—Captopril—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Nebivolol—Asthenia—Leflunomide—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Nebivolol—Pruritus—Leflunomide—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Nebivolol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Nebivolol—Dizziness—Azathioprine—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Nebivolol—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Nebivolol—Asthenia—Mycophenolic acid—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Nebivolol—Diarrhoea—Leflunomide—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Nebivolol—Urticaria—Lisinopril—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Nebivolol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Nebivolol—Abdominal pain—Lisinopril—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Nebivolol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Nebivolol—Pruritus—Mycophenolic acid—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Nebivolol—Vomiting—Azathioprine—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Nebivolol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Nebivolol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Nebivolol—Rash—Azathioprine—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Nebivolol—Dermatitis—Azathioprine—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Nebivolol—Headache—Azathioprine—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Nebivolol—Dizziness—Leflunomide—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Nebivolol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Nebivolol—Vomiting—Leflunomide—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Nebivolol—Hypersensitivity—Lisinopril—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Nebivolol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Nebivolol—Rash—Leflunomide—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Nebivolol—Dermatitis—Leflunomide—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Nebivolol—Mental disorder—Prednisone—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Nebivolol—Nausea—Azathioprine—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Nebivolol—Headache—Leflunomide—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Nebivolol—Malnutrition—Prednisone—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Nebivolol—Asthenia—Lisinopril—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Nebivolol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Nebivolol—Pruritus—Lisinopril—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Nebivolol—Vomiting—Mycophenolic acid—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Nebivolol—Rash—Mycophenolic acid—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Nebivolol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Nebivolol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Nebivolol—Headache—Mycophenolic acid—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Nebivolol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Nebivolol—Nausea—Leflunomide—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Nebivolol—Diarrhoea—Lisinopril—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Nebivolol—Angioedema—Prednisone—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Nebivolol—Dizziness—Lisinopril—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Nebivolol—Nausea—Mycophenolic acid—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Nebivolol—Vertigo—Prednisone—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Nebivolol—Syncope—Prednisone—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Nebivolol—Cardiac disorder—Methotrexate—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Nebivolol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Nebivolol—Loss of consciousness—Prednisone—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Nebivolol—Vomiting—Lisinopril—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Nebivolol—Rash—Lisinopril—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Nebivolol—Dermatitis—Lisinopril—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Nebivolol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Nebivolol—Headache—Lisinopril—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Nebivolol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Nebivolol—Mental disorder—Methotrexate—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Nebivolol—Malnutrition—Methotrexate—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Nebivolol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Nebivolol—Nausea—Lisinopril—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Nebivolol—Shock—Prednisone—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Nebivolol—Nervous system disorder—Prednisone—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Nebivolol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Nebivolol—Skin disorder—Prednisone—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Nebivolol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Nebivolol—Rash—Mycophenolate mofetil—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Nebivolol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Nebivolol—Headache—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Nebivolol—Vertigo—Methotrexate—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Nebivolol—Insomnia—Prednisone—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Nebivolol—Paraesthesia—Prednisone—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Nebivolol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Nebivolol—Chest pain—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Nebivolol—Fatigue—Prednisone—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Nebivolol—Nervous system disorder—Methotrexate—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Nebivolol—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Nebivolol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Nebivolol—Skin disorder—Methotrexate—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Nebivolol—Urticaria—Prednisone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Nebivolol—Abdominal pain—Prednisone—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Nebivolol—Insomnia—Methotrexate—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Nebivolol—Paraesthesia—Methotrexate—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Nebivolol—Dyspnoea—Methotrexate—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Nebivolol—Somnolence—Methotrexate—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Nebivolol—Hypersensitivity—Prednisone—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Nebivolol—Fatigue—Methotrexate—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Nebivolol—Asthenia—Prednisone—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Nebivolol—Pruritus—Prednisone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Nebivolol—Diarrhoea—Prednisone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Nebivolol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Nebivolol—Urticaria—Methotrexate—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Nebivolol—Dizziness—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Nebivolol—Abdominal pain—Methotrexate—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Nebivolol—Vomiting—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Nebivolol—Rash—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Nebivolol—Dermatitis—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Nebivolol—Headache—Prednisone—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Nebivolol—Hypersensitivity—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Nebivolol—Asthenia—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Nebivolol—Nausea—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Nebivolol—Pruritus—Methotrexate—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Nebivolol—Diarrhoea—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Nebivolol—Dizziness—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Nebivolol—Vomiting—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Nebivolol—Rash—Methotrexate—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Nebivolol—Dermatitis—Methotrexate—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Nebivolol—Headache—Methotrexate—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Nebivolol—Nausea—Methotrexate—systemic scleroderma	0.000975	0.000975	CcSEcCtD
